Project Details
Description
Niclosamide or Pyrvinium and BAY-876 as a Combination for Triple Negative Breast Cancer Treatment
Status | Finished |
---|---|
Effective start/end date | 1/1/22 → 8/31/23 |
Funding
- Whiteside Inst. for Clinical Research
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.